ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
654
Frequently Asked Questions
What is Market Cap of Acadia Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Acadia Pharmaceuticals Inc market cap is $4.02B.
What is the 52-week high for Acadia Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Acadia Pharmaceuticals Inc 52 week high is $26.65 as of September 11, 2025.
What is the 52-week low for Acadia Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Acadia Pharmaceuticals Inc 52 week low is $13.40 as of September 11, 2025.
What is Acadia Pharmaceuticals Inc stock price today?
Acadia Pharmaceuticals Inc stock price today is $23.80.
What was Acadia Pharmaceuticals Inc stock price yesterday?
Acadia Pharmaceuticals Inc stock price yesterday was $24.84.
What is the PE ratio of Acadia Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Acadia Pharmaceuticals Inc’s P/E ratio is 17.88.
What is the Price-to-Book ratio of Acadia Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Acadia Pharmaceuticals Inc P/B ratio is 4.8796.
What is the 50-day moving average of Acadia Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Acadia Pharmaceuticals Inc 50-day moving average is $23.79.
How many employess does Acadia Pharmaceuticals Inc has?